Another view of therapy for cognition in schizophrenia

被引：101

作者：

Carpenter, WT ^{[1
]}

Gold, JM ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA

来源：

BIOLOGICAL PSYCHIATRY | 2002年 / 51卷 / 12期

关键词：

D O I：

10.1016/S0006-3223(02)01399-9

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：969 / 971

页数：3

共 22 条

[1]

BILDER RM, 1992, PSYCHOPHARMACOL BULL, V28, P353

[2]

Blyer CR, 2000, COGNITIVE FUNCTIONIN, P241

[3] Uneasy alliance - Clinical investigators and the pharmaceutical industry [J].

Bodenheimer, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1539-1544

[4] THE COMPARATIVE EFFICACY AND LONG-TERM EFFECT OF CLOZAPINE TREATMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE [J].

BUCHANAN, RW ;

HOLSTEIN, C ;

BREIER, A .

BIOLOGICAL PSYCHIATRY, 1994, 36 (11) :717-725

[5] NEUROLEPTICS - EFFECTS ON NEUROPSYCHOLOGICAL FUNCTION IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].

CASSENS, G ;

INGLIS, AK ;

APPELBAUM, PS ;

GUTHEIL, TG .

SCHIZOPHRENIA BULLETIN, 1990, 16 (03) :477-499

[6]

Castner SA, 2000, SCIENCE, V289, P57

[7] Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [J].

Geddes, J ;

Freemantle, N ;

Harrison, P ;

Bebbington, P .

BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1371-1376

[8]

GOLD JM, 2000, ADV PRECLINICAL CLIN, V2, P15

[9]

Green MF, 1997, AM J PSYCHIAT, V154, P799

[10] The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone [J].

Green, MF ;

Marder, SR ;

Glynn, SM ;

McGurk, SR ;

Wirshing, WC ;

Wirshing, DA ;

Liberman, RP ;

Mintz, J .

BIOLOGICAL PSYCHIATRY, 2002, 51 (12) :972-978

← 1 2 3 →